18.02.2025 • NewsTotalEnergiesAir Liquidegreen hydrogen

TotalEnergies and Air Liquide to Invest €1 Billion in Dutch Green Hydrogen Projects

TotalEnergies and Air Liquide have signed agreements to develop two projects in the Netherlands, for the production and delivery of some 45,000 t/y of green hydrogen produced using renewable power, generated mostly by the OranjeWind offshore wind farm, developed by TotalEnergies (50%) and RWE (50%).

These projects are expected to cut CO2 emissions from TotalEnergies’ refineries in Belgium and the Netherlands by up to 450,000 t/y and contribute to the European renewable energy targets in transport.

Upon completion, the two projects would represent a combined investment of more than €1 billion.

Under the first agreement, the two companies plan to set up a joint venture, equally held by TotalEnergies (50%) and Air Liquide (50%), which will build and operate a 250 MW electrolyzer near the Zeeland refinery. This project is expected to enable the production of up to 30,000 t/y of green hydrogen, most of which will be delivered to Zeeland’s platform. The electrolyzer is scheduled to be commissioned in 2029 and will cut the site’s CO2 emissions by up to 300,000 t/y.

In addition, as part of Air Liquide's 200 MW ELYgator electrolyzer project located in Maasvlakte, Netherlands, TotalEnergies has signed a tolling agreement for 130 MW to be dedicated to the production of 15,000 t/y of green hydrogen for its platform in Antwerp. Under this agreement, TotalEnergies will supply the renewable electrons produced by the OranjeWind project to Air Liquide to be transformed into green hydrogen. The project is expected to be operational by the end of 2027 and will reduce CO2 emissions at the Antwerp site by up to 150,000 t/y.

© TotalEnergies
© TotalEnergies

“Following the first partnership agreement with Air Liquide to supply the Normandy refinery with green hydrogen, and the agreements to supply the Grandpuits and La Mède biorefineries with renewable hydrogen, the partnership with Air Liquide takes on a new dimension and marks a new step in TotalEnergies' ambition to decarbonize the hydrogen consumed by its refineries in Europe by 2030,” said Vincent Stoquart, president, Refining & Chemicals at TotalEnergies.

Emilie Mouren-Renouard, member of Air Liquide’s executive committee and in charge of operations in Europe, added: “Flagship projects such as the ones we are announcing today, will play a key role in reducing emissions, particularly in hard-to-abate sectors such as industry and heavy mobility. […] These two projects will complete the five Air Liquide low carbon units already in operation or construction in Europe.”

Company

TotalEnergies SE

Tour Coupole 2, place Jean Millier - Arche Nord - Coupole/Regnault
92078 Paris
France

Company contact







Artificial Intelligence

Pierre Racz: "Real Artificial Intelligence Does Not Exist"
part one of a three-part interview series

Pierre Racz: "Real Artificial Intelligence Does Not Exist"

In part one Pierre Racz, President of Genetec, is addressing why IP network video systems were the game changer in the industry and why he does not like the term AI.

Whitepaper

Cannabis Extraction — Temperature Control Systems in Action

Cannabis Extraction — Temperature Control Systems in Action

Cannabis is a crop that has been cultivated for thousands of years and contains many pharmacologically active substances.

most read

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.